Detalhe da pesquisa
1.
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.
Biol Blood Marrow Transplant
; 25(10): 2002-2007, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31260802
2.
Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia.
Leuk Res
; 97: 106432, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32911375